Plaque Psoriasis
📧 Sign up to get email alerts when something new happens for Plaque Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: A Safety and Efficacy Study of DRM02 in Subjects With Plaque Psoriasis [Phase 2]
Phase 2 trial update for DRM02 in plaque psoriasis reports safety and efficacy data.
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Plaque Psoriasis [Phase 2]
Phase 2 trial assessing the efficacy of ZPL-3893787 in subjects with plaque psoriasis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-07-13Clinical Trial Update: Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque Psoriasis [Phase 3]
Phase 3 trial comparing risankizumab to secukinumab in moderate-to-severe plaque psoriasis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-08Clinical Trial Update: Safety, Pharmacokinetics and Efficacy of ARQ-151 Cream in Adults With Mild to Moderate Chronic Plaque Psoriasis [Phase 1, Phase 2]
A clinical trial update for ARQ-151 cream in adults with mild to moderate chronic plaque psoriasis reports safety, pharmacokinetics, and pre…
-
CLINICAL_TRIALS trial_result · 2021-06-25Clinical Trial Update: A Study of Ixekizumab (LY2439821) in Chinese Participants With Moderate-to-Severe Plaque Psoriasis [Phase 3]
Phase 3 trial update of ixekizumab in Chinese participants with moderate-to-severe plaque psoriasis completed, with results posted in 2021.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-06-07Clinical Trial Update: Efficacy and Safety of 2 Secukinumab Regimens in 90kg or More Weight Group With Moderate/Severe Chronic Plaque Psoriasis [Phase 3]
Phase 3 trial evaluating two secukinumab regimens in patients weighing 90 kg or more with moderate to severe chronic plaque psoriasis; study…
-
CLINICAL_TRIALS trial_result · 2021-05-17Clinical Trial Update: Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy [Phase 3]
Phase 3 trial comparing apremilast to placebo for mild-to-moderate plaque psoriasis. Safety and efficacy results were posted in May 2021.
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: An International Multicenter, Randomized, Double-blind, Placebo-Controlled Clinical Study of Efficacy and Safety of Two Dosing Regimens of BCD-085 (JSC BIOCAD, Russia) in Patients With Moderate to Severe Plaque Psoriasis [Phase 3]
Phase 3 randomized trial evaluating two dosing regimens of BCD-085 for moderate to severe plaque psoriasis; study completed with results pos…
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: A Study to Assess Usability of Risankizumab Autoinjector Combination Product in Participants With Moderate to Severe Plaque Psoriasis [Phase 3]
Phase 3 trial update evaluating usability of a risankizumab autoinjector combination product in adults with moderate to severe plaque psoria…
-
CLINICAL_TRIALS trial_result · 2021-05-10Clinical Trial Update: A Safety Study of 188-0551 Spray Versus Reference Listed Drug (RLD) in Adult Subjects With Plaque Psoriasis [Phase 2]
A Phase 2 safety study comparing spray 188-0551 to the reference listed drug in adults with plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2021-04-09Clinical Trial Update: Efficacy 、Safety and PK of SHR-1314 in Patients With Moderate-to-Severe Plaque Psoriasis [Phase 3]
Phase 3 trial update on SHR-1314 assessing efficacy, safety, and pharmacokinetics in moderate-to-severe plaque psoriasis.
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: AGN-242428 in the Treatment of Plaque Psoriasis [Phase 2]
Phase 2 trial of AGN-242428 for plaque psoriasis was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-03-30Clinical Trial Update: A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2) [Phase 3]
Phase 3 trial comparing mirikizumab to secukinumab and placebo in moderate-to-severe plaque psoriasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-23Clinical Trial Update: International Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of BCD-085 in Various Doses in Patients With Moderate to Severe Plaque Psoriasis [Phase 2]
Phase 2 trial assessing multiple subcutaneous doses of BCD-085 for plaque psoriasis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-03-16Clinical Trial Update: A Study to Assess Safety and Efficacy of Risankizumab Using a New Formulation in Participants With Moderate to Severe Plaque Psoriasis [Phase 3]
Phase 3 trial evaluating a new formulation of risankizumab for safety and efficacy in moderate to severe plaque psoriasis has completed with…
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: Enstilar® Foam in the Treatment of Chronic Plaque Psoriasis in Patients With Skin of Color [Phase 4]
Phase 4 trial update evaluating Enstilar Foam for chronic plaque psoriasis in patients with skin of color; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2021-01-06Clinical Trial Update: A Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Bimekizumab in Patients With Chronic Plaque Psoriasis [Phase 2]
A Phase 2 study evaluating the pharmacokinetics, pharmacodynamics, and safety of bimekizumab in adults with plaque psoriasis has completed a…
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque Psoriasis [Phase 2]
Phase 2 dose-finding trial evaluating AEB071 in patients with moderate to severe plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2020-11-20Clinical Trial Update: Efficacy and Safety of Sorilux in Maintenance Treatment of Moderate Type Plaque Psoriasis [Phase 4]
Phase 4 trial assessing the efficacy and safety of Sorilux for maintenance treatment in moderate plaque psoriasis.
-
CLINICAL_TRIALS trial_result · 2020-11-19Clinical Trial Update: Study to Evaluate Safety and Efficacy of Different Doses of Bimekizumab in Patients With Chronic Plaque Psoriasis [Phase 2]
Phase 2 trial evaluating safety and efficacy of different doses of bimekizumab in chronic plaque psoriasis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-09Clinical Trial Update: The Safety & Efficacy of Etanercept in Psoriasis Patients Who Have Not Responded to Adalimumab [Phase 4]
Phase 4 trial update evaluating the safety and efficacy of etanercept in psoriasis patients unresponsive to adalimumab.
-
CLINICAL_TRIALS trial_result · 2020-10-05Clinical Trial Update: Patient Satisfaction Following Twice Daily Dosing With DFD-01 in Subjects With Moderate Plaque Psoriasis [Phase 4]
A Phase 4 clinical trial assessing patient satisfaction with twice-daily dosing of DFD-01 in adults with moderate plaque psoriasis has compl…
-
CLINICAL_TRIALS trial_result · 2020-08-28Clinical Trial Update: An Efficacy, Safety, and Pharmacokinetics Study of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Participants Greater Than or Equal to 6 to Less Than 12 Years of Age [Phase 3]
Phase 3 trial evaluating subcutaneously administered ustekinumab for moderate to severe chronic plaque psoriasis in pediatric patients aged …
-
CLINICAL_TRIALS trial_result · 2020-08-26Clinical Trial Update: The Effect of Enstilar Versus Vehicle on Target Lesions in Moderate Plaque Type Psoriasis Patients [Phase 4]
Phase 4 trial comparing Enstilar to vehicle on target lesions in adults with moderate plaque psoriasis; results completed and posted.
-
CLINICAL_TRIALS trial_result · 2020-08-20Clinical Trial Update: Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis [Phase 3]
Phase 3 trial updates safety and efficacy of IDP-118 in treating plaque psoriasis; results posted after completion in 2020.